Thomas Ginsburg is a 16-year Hodgkins Lymphoma sur”thrivor” and an active volunteer with the Pacific Northwest Chapter of the Leukemia & Lymphoma Society. Known to the chapter as “Team Tom”, he is passionate about improving the quality of life of blood cancers patients and their families and serves in variety of volunteer roles with a preternatural positive attitude, infectious humor, and a bottomless well of enthusiasm.
As moderator of the Management of Disease and Treatment Side Effects panel, he looks forward to facilitating a meaningful discussion that incorporates a patient’s perspective in all phases of survivorship, from diagnosis, through treatment, and to living well beyond treatment.
He lives in DuPont, with his wife, Bianca, a breast cancer survivor, and is the reigning Princess of the 2017 Auburn ACS Relay for Life. He is outdoors as often as possible hiking, birding, and kayaking on the Eastern Reach of the Nisqually River.
Ryan Lynch, MD is an Assistant Professor of Medicine at the University of Washington and Fred Hutch Cancer Center. He is a member on the NCCN Guidelines Committee for Hodgkin Lymphoma, and currently engages in clinical research for both Hodgkin and non-Hodgkin lymphoma with a focus on integration of novel therapies like immunotherapy into the management of these cancers
Swathi Namburi, MD is a hematologist at Swedish Cancer Institute specializing in a variety of blood cancers. She has a focus in multiple myeloma at Swedish, and has experience in chemotherapy, immunotherapy, and a variety of cellular therapies. Additionally, she participates as an investigator on numerous clinical trials.
Rahul Banerjee, MD, FACP is an Assistant Professor in the Division of Medical Oncology at the University of Washington; he also holds a faculty appointment at the Fred Hutchinson Cancer Center. He previously completed his hematology/oncology fellowship and advanced BMT/CAR-T fellowship at the University of California San Francisco. His clinical interests are in multiple myeloma, AL amyloidosis, and CAR-T therapy. His research interests are in toxicity management, digital health, and the patient experience.
Samuel Jonas, LSWAIC, is a social worker at the Swedish Cancer Institute and is a member of the Association of Oncology Social Work (AOSW). He works within the Swedish Center for Blood Disorders and Stem Cell Transplantation and is a passionate advocate for patients as they seek care.